Table 2

Incidence rates, IR (per 1 person-year), incidence rates ratios, IRR, of reasons of treatment modifications the first year after initiation of HAART according to gender
Toxicity IR (95% CI) Other/Unknown IR (95% CI) Toxicity IRR (95% CI) Other/Unknown IRR (95% CI)
Adjusted for all listed confounders,
Men 0.52 (0.42-0.64) 0.55 (0.44-0.68) 1.00 1.00
Women 0.49 (0.41-0.59) 0.57 (0.48-0.67) 0.97 (0.66-1.44) 1.18 (0.76-1.85)
Women (pregnant excluded) 0.54 (0.45-0.66) 0.49 (0.40-0.61) 1.03 (0.69-1.52) 1.14 (0.71-1.82)

Poisson regression analyses of incidence rates, IR (95% CI), and incidence rates ratios, IRR (95% CI), adjusted by time-updated age, race, time-updated CD4 count, time-updated viral load, prior or current AIDS at HAART initiation, body weight and initiation period (< January 1st 2003 and >= January 1st 2003).

Thorsteinsson et al.

Thorsteinsson et al. BMC Infectious Diseases 2012 12:293   doi:10.1186/1471-2334-12-293

Open Data